OPS – Newsletter – Oregon Psilocybin Services (OPS) and Oregon Medical Marijuana Program (OMMP) will merge and become the Oregon Medical Cannabis & Psilocybin (MCAP) section

280 X180 white to post to websites – 2026-08-22T100513.218 copy

Oregon Psilocybin Services (OPS) and Oregon Medical Marijuana Program (OMMP) will merge and become the Oregon Medical Cannabis & Psilocybin (MCAP) section

On June 29^th, Oregon Health Authority announced changes to the Oregon Psilocybin Services (OPS) section.

Due to budget challenges, OPS and the Oregon Medical Marijuana Program (OMMP) will come together to form one section, the Medical Cannabis & Psilocybin (MCAP) section.

Angie Allbee, OPS section manager, will lead MCAP, and Megan Lockwood, OMMP section manager, will lead the Health Licensing Office (HLO).

2026 Rulemaking Update

The 2026 Rules Advisory Committee (RAC) meetings have concluded. RAC members discussed proposed rules, which included significant changes to all license fees, including elimination of reduced fees.

OPS has considered RAC input and is preparing the next version of proposed rules for public comment period, which begins September 1, 2026, and concludes on September 21, 2026. OPS will publish the revised rules for public comment on September 1, 2026, on the Administrative Rules and Rulemaking Process page on the OPS website.

To share your feedback, please participate in the 21-day public comment period scheduled for September 1-21, 2026. At that time, members of the public are invited to email written comments or provide verbal comments at the virtual public hearings on September 15 and 16, 2026.

After the public comment period concludes in September, OPS will finalize administrative rules by filing with the Oregon Secretary of State. Revised rules will become effective on January 1, 2027.

Please note, we will not be receiving public feedback on proposed rules prior to the public comment period in September.

2025 Year-in-Review and 2025 Year-End Data Summary

OPS publishes an annual summary of accomplishments each year. The 2025 Year-in-Review is now available on the OPS Annual Reports and Quarterly Newsletters webpage.

This year, OPS also published a new 2025 Year-End Data Summary which provides annual totals of 2025 data presented on the OPS Data Dashboard. This includes data related to licensing, compliance, safety, adverse reactions, product and sales, client demographics, and client reasons for accessing psilocybin services.

2026 Public Listening Sessions

Thank you to all who participated in the Public Listening Sessions on May 6, and May 8, 2026. We received thoughtful comments and important questions. In case you missed it, OPS published a 2026 Public Listening Sessions Summary that summarizes themes and provides answers to questions asked during the two listening sessions.

Recordings of the sessions can also be accessed on the OPS 2026 Public Listening Sessions webpage in English, Spanish, and American Sign Language (ASL).

We appreciate your feedback and hope you will join us again in September for the virtual public hearings on proposed rules.

July 2026 Rule Petition Public Comment Period

The Oregon Health Authority (OHA), Public Health Division received a petition to amend OAR 333-333-3010, the Psilocybin Training Program Curriculum Approval Process.

Members of the public can submit comments through August 29, 2026. For more information please go to the OPS July 2026 Rule Petition page.

Rules Advisory Committee for Psilocybin Testing

The Oregon Environmental Laboratory Accreditation Program (ORELAP) convened a Rules Advisory Committee (RAC) this week to discuss changes to psilocybin product testing regulations and rules found in Division 64 – Accreditation of Laboratories.

For more information about this rulemaking, please go to the ORELAP Rules and Statutes webpage.

OPS Data Dashboard Updates: New OPS Data Includes Veteran Status

The first quarter (Q1) of 2026 data is now available on the Oregon Psilocybin Services (OPS) Data Dashboard.

OPS updated the 303 Client Data Form in 2026 to comply with the passage of HB 2387 in 2025, which amends ORS 475A to require the collection of ‘veteran status’ of clients. Among clients who responded to the question January 1 – March 31 (Q1) of this year, 30 clients identified as veterans.

The 303 Client Data Form also asks clients for their reasons for seeking psilocybin services. From January 1, 2025 to March 31, 2026, 77 clients responded that they accessed psilocybin services to address trauma related to combat or military service.
PTSD and some other mental health conditions affect veterans at higher rates than the general population. There is growing research examining how psychedelic substances can treat some of these conditions. A recent report on Veterans and Psychedelics explains more.
If you or a loved one is a veteran in need of support or services, you can find resources on the Oregon Health Authority’s Veteran and Military Behavioral Health webpage.

Veteran Boating

OPS Data Dashboard Updates: New Information About Client ‘Opt-Out’ Data

Beginning in 2026, service centers are required to report the number of clients who “opt-out” of having their 303 data included in the total numbers (aggregate data) submitted to OPS. This means that the responses from clients who selected this option are excluded from total number compiled and reported to OPS by service centers for that quarter. This is important information that helps provide a more accurate understanding of the total number of clients receiving psilocybin services in Oregon. The number of clients who selected the “opt-out” option is reported on the Client Demographic Page of the OPS Data Dashboard.

Since the start of collecting this information in Q1 of 2026 (January 1, 2026, to March 31, 2026), 139 clients selected the “opt-out” box.
- This is different than selecting “don’t want to answer” for individual questions on the 303 Client Data Form.
During this same time period (January 1, 2026, to March 31, 2026), OPS received the total numbers (aggregate data) from 952 completed 303 Client Data Forms.
- Based on this information, during Q1 of 2026, 7% of clients selected the opt-out option out of the total of 1,091 clients who received psilocybin services in Oregon (952 clients served + 139 clients opted-out).

OPS Data Dashboard Updates: New Compliance Data on Administrative Violations

Beginning in 2026, OPS is reporting new data on administrative hearings on the Compliance Page of the OPS Data Dashboard. This includes the number of administrative hearings requested, withdrawn, and completed. This information is shared in the interest of transparency and providing additional data on ongoing compliance work done by OPS.

Also, in addition to reporting the number of administrative violations, OPS is now reporting the total number of administrative violations issued by category of severity and license type. This new information is now available to view on the Compliance Page of the OPS Data Dashboard. The category of a violation is related to the severity of risk to public health and safety. For more information on categories of OPS’s administrative violations, please reference OAR 333-333-6200.

Final orders are categorized based on type of administrative action, however, to understand the details please reference the Final Orders on the Final Orders webpage.

Oregon Psilocybin Advisory Board

The Oregon Psilocybin Advisory Board (OPAB) met on August 7, 2026. All OPAB meetings are public meetings, and meeting materials and recordings can be accessed on the OPAB webpage. The next quarterly OPAB meeting is scheduled for November 6, 2026, from 9:00 – Noon, Pacific Time.

Community Partner Collaborations

OPS is interested in partnering with community-based organizations to explore how we can work together to increase public awareness, community engagement, and collaborations that support the SHIP strategy to destigmatize the use of psilocybin as a culturally responsive option for healing and wellness.

If you know of a community-based organization that would like to join this conversation, please email us at: OHA.psilocybin@oha.oregon.gov